Literature DB >> 18371358

Generation of induced pluripotent stem cells in the absence of drug selection.

Robert Blelloch, Monica Venere, Jonathan Yen, Miguel Ramalho-Santos.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 18371358      PMCID： PMC2894698          DOI： 10.1016/j.stem.2007.08.008

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN： 1875-9777            Impact factor:   24.633


× No keyword cloud information.
  7 in total

1.  N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation.

Authors:  B A Malynn; I M de Alboran; R C O'Hagan; R Bronson; L Davidson; R A DePinho; F W Alt
Journal:  Genes Dev       Date:  2000-06-01       Impact factor: 11.361

2.  LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism.

Authors:  Peter Cartwright; Cameron McLean; Allan Sheppard; Duane Rivett; Karen Jones; Stephen Dalton
Journal:  Development       Date:  2005-01-26       Impact factor: 6.868

3.  Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution.

Authors:  Nimet Maherali; Rupa Sridharan; Wei Xie; Jochen Utikal; Sarah Eminli; Katrin Arnold; Matthias Stadtfeld; Robin Yachechko; Jason Tchieu; Rudolf Jaenisch; Kathrin Plath; Konrad Hochedlinger
Journal:  Cell Stem Cell       Date:  2007-06-07       Impact factor: 24.633

4.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

5.  Generation of germline-competent induced pluripotent stem cells.

Authors:  Keisuke Okita; Tomoko Ichisaka; Shinya Yamanaka
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

6.  In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state.

Authors:  Marius Wernig; Alexander Meissner; Ruth Foreman; Tobias Brambrink; Manching Ku; Konrad Hochedlinger; Bradley E Bernstein; Rudolf Jaenisch
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

Review 7.  Strategies and new developments in the generation of patient-specific pluripotent stem cells.

Authors:  Shinya Yamanaka
Journal:  Cell Stem Cell       Date:  2007-06-07       Impact factor: 24.633
  7 in total
  102 in total

Review 1.  Induced pluripotent stem cells--opportunities for disease modelling and drug discovery.

Authors:  Marica Grskovic; Ashkan Javaherian; Berta Strulovici; George Q Daley
Journal:  Nat Rev Drug Discov       Date:  2011-11-11       Impact factor: 84.694

Review 2.  Using human pluripotent stem cells to untangle neurodegenerative disease mechanisms.

Authors:  Brigitte Malgrange; Laurence Borgs; Benjamin Grobarczyk; Audrey Purnelle; Patricia Ernst; Gustave Moonen; Laurent Nguyen
Journal:  Cell Mol Life Sci       Date:  2010-10-26       Impact factor: 9.261

3.  Production of mice using iPS cells and tetraploid complementation.

Authors:  Xiao-Yang Zhao; Zhuo Lv; Wei Li; Fanyi Zeng; Qi Zhou
Journal:  Nat Protoc       Date:  2010-04-29       Impact factor: 13.491

Review 4.  Embryonic and induced pluripotent stem cells as a model for liver disease.

Authors:  Hiroshi Yagi; Edgar Tafaleng; Masaki Nagaya; Marc C Hansel; Stephen C Strom; Ira J Fox; Alejandro Soto-Gutierrez
Journal:  Crit Rev Biomed Eng       Date:  2009

5.  Towards an optimized culture medium for the generation of mouse induced pluripotent stem cells.

Authors:  Jiekai Chen; Jing Liu; Qingkai Han; Dajiang Qin; Jianyong Xu; You Chen; Jiaqi Yang; Hong Song; Dongshan Yang; Meixiu Peng; Wenzhi He; Ronghui Li; Hao Wang; Yi Gan; Ke Ding; Lingwen Zeng; Liangxue Lai; Miguel A Esteban; Duanqing Pei
Journal:  J Biol Chem       Date:  2010-07-01       Impact factor: 5.157

Review 6.  Induced pluripotency: history, mechanisms, and applications.

Authors:  Matthias Stadtfeld; Konrad Hochedlinger
Journal:  Genes Dev       Date:  2010-10-15       Impact factor: 11.361

7.  Proliferative capacity and pluripotent characteristics of porcine adult stem cells derived from adipose tissue and bone marrow.

Authors:  Lina Tang; Yupeng Yin; Haole Zhou; Guangqi Song; Anran Fan; Bo Tang; Wei Shi; Ziyi Li
Journal:  Cell Reprogram       Date:  2012-07-09       Impact factor: 1.987

8.  Recurrent trisomy and Robertsonian translocation of chromosome 14 in murine iPS cell lines.

Authors:  Qian Chen; Xiaoyun Shi; Cornelia Rudolph; Yong Yu; Ding Zhang; Xiaoyu Zhao; Sabine Mai; Gang Wang; Brigitte Schlegelberger; Qinghua Shi
Journal:  Chromosome Res       Date:  2011-10-19       Impact factor: 5.239

9.  A reprogrammable mouse strain from gene-targeted embryonic stem cells.

Authors:  Matthias Stadtfeld; Nimet Maherali; Marti Borkent; Konrad Hochedlinger
Journal:  Nat Methods       Date:  2009-12-13       Impact factor: 28.547

10.  Regulatory issues for personalized pluripotent cells.

Authors:  Maureen L Condic; Mahendra Rao
Journal:  Stem Cells       Date:  2008-07-31       Impact factor: 6.277
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.